and recommendation
BioTime, Inc. (BTX)
BioTime (NYSEMKT: BTX), a clinical-stage biotechnology company, focuses on developing and commercializing products addressing degenerative diseases based on pluripotent stem cells and HyStem cell/drug delivery platform technologies.
BTX’s product candidates include Renevia, a facial aesthetics product that is in pivotal clinical trial for the treatment of HIV related facial lipoatrophy; OpRegen, which is in Phase I/IIa clinical trial for the treatment of the dry form of age-related macular degeneration; HyStem-BDNF, a preclinical development program for the delivery of recombinant human brain-derived neurotrophic factor (BDNF) directly into the stroke cavity of patients for aiding in tissue repair and functional recovery; and ReGlyde that is in preclinical development as a device for viscosupplementation and a combination product for drug delivery in osteoarthritis.
BTX also develops AST-OPC1, a therapy derived from pluripotent stem cells that is in a Phase I/IIa clinical trial for spinal cord injuries; AST-VAC1, a patient-specific cancer immunotherapy that is in Phase II clinical trial for acute myeloid leukemia; and AST-VAC2, a non-patient specific cancer immunotherapy, which is in Phase I/IIa clinical trial to treat non-small cell lung cancer. In addition, it offers liquid biopsy tests for diagnosis of cancer; bone grafting products to treat orthopedic disorders; and mobile health software products.
Further, it markets GeneCards, a human gene database; LifeMap Discovery, a database of embryonic development, stem cell research, and regenerative medicine; MalaCards, a human disease database; VarElect, an application for prioritizing gene variants; and GeneAnalytics, a novel gene set analysis tool. Additionally, the company develops and markets Hextend, a blood plasma volume expander used for the treatment of hypovolemia.
BioTime, Inc. was founded in 1990 and is based in Alameda, California.
- October 18, 2012 - 9:27am | IP & Patents
- September 28, 2012 - 12:47pm | BOD & C-Suite Updates
- August 27, 2012 - 8:00am | Research Notes
- August 16, 2012 - 8:08am | Scoreboard at a Glance
- August 10, 2012 - 10:16am | Earnings
- May 16, 2012 - 9:07am | Scoreboard at a Glance
- May 11, 2012 - 10:13am | Earnings
- April 23, 2012 - 9:39am | Research Notes
- April 20, 2012 - 8:18am
- March 23, 2012 - 9:38am
- March 18, 2012 - 12:05pm
- March 18, 2012 - 10:40am
- January 24, 2012 - 10:09am
- December 21, 2011 - 10:44am
- November 19, 2011 - 12:05pm
- November 14, 2011 - 1:35pm
- October 4, 2011 - 10:13am
- September 6, 2011 - 8:08am
- August 24, 2011 - 9:01am
- August 19, 2011 - 8:12am